On June 25, 2026, OSferionBiomaterials Corp. (OSB), a member of OrthoActiVolution Holdings Inc. (OAV), was selected for the FY2027 Medical Device Industry Infrastructure Enhancement Grant (R&D and Commercialization Program), administered by the Shizuoka Industrial Foundation.

This grant supports initiatives aimed at strengthening the foundation of the vital healthcare industry through the promotion of domestic pharmaceutical and medical device manufacturing, digital transformation, and the development of remote and contactless healthcare solutions.

Through this grant, OSferionBiomaterials (OSB) will continue to advance the research, development, and commercialization of innovative technologies and products in the medical device field.

For more information (Japanese) (External Link): https://www.biomaterial.co.jp/news/201/